ANNX vs OLMA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OLMA Captures Institutional Edge (2โ1 Pillars ยท 2โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Olema Pharmaceuticals, Inc. Common Stock (OLMA) driven by superior Growth & Margin, Options & Structure while ANNX counters with relative strength in Momentum & Technical. Fundamentally, ANNX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus OLMA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ANNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro) against OLMA sits in BREAKDOWN (18th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ANNX | OLMA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $747.8M | $662.3M | Larger Scale | ANNX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -130.8% | -69.8% | Higher ROE | OLMA |
| 52-Week Range Position Momentum | 18% ($3โ$7) | 3% ($6โ$36) | Stronger Trend | ANNX |
| Beta / 30D Volatility Risk Regime | 1.69ฮฒ ยท 63% Vol | 1.81ฮฒ ยท 83% Vol | Lower Realized Risk | ANNX |
| Unified Institutional Score Composite Signal | 43.5 / 100 (HOLD) | 43.8 / 100 (HOLD) | Higher Composite | OLMA |